title: Viral kinetic modeling: state of the art.
abstract: Viral kinetic (VK) modeling has led to increased understanding of the within host dynamics of viral infections and the effects of therapy. Here we review recent developments in the modeling of viral infection kinetics with emphasis on two infectious diseases: hepatitis C and influenza. We review how VK modeling has evolved from simple models of viral infections treated with a drug or drug cocktail with an assumed constant effectiveness to models that incorporate drug pharmacokinetics and pharmacodynamics, as well as phenomenological models that simply assume drugs have time varying-effectiveness. We also discuss multiscale models that include intracellular events in viral replication, models of drug-resistance, models that include innate and adaptive immune responses and models that incorporate cell-to-cell spread of infection. Overall, VK modeling has provided new insights into the understanding of the disease progression and the modes of action of several drugs. We expect that VK modeling will be increasingly used in the coming years to optimize drug regimens in order to improve therapeutic outcomes and treatment tolerability for infectious diseases.
authors: Theoretical Biology and Biophysics, MS-K710, Los Alamos National Laboratory, Los Alamos, NM, 87545, USA.
authors: Laetitia
authors: L
authors: Canini
authors: Alan S
authors: AS
authors: Perelson
mesh_terms: D000998:Antiviral Agents / Q000493:pharmacokinetics* / Q000494:pharmacology* / Q000627:therapeutic use; D003198:Computer Simulation; D018450:Disease Progression; D006526:Hepatitis C / Q000188:drug therapy* / Q000276:immunology / Q000821:virology*; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy* / Q000276:immunology / Q000821:virology*; D008954:Models, Biological
chemical_list: D000998:Antiviral Agents